Get started
COCHLEAR LTDCOCHLEAR LTDCOCHLEAR LTD

COCHLEAR LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

OC5 chart


Full chart

OC5 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.92 B‬ EUR
Dividend yield (indicated)
1.93%
Price to earnings Ratio (TTM)
50.96
Basic EPS (TTM)
3.32 EUR
Net income (FY)
‪217.09 M‬ EUR
Revenue (FY)
‪1.32 B‬ EUR
Shares float
‪61.06 M‬
Beta (1Y)
0.46

Employees


Employees (FY)
‪5.5 K‬
Change (1Y)
+500 +10.00%
Revenue / Employee (1Y)
‪239.10 K‬ EUR
Net income / Employee (1Y)
‪39.47 K‬ EUR

About COCHLEAR LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Diggory William Howitt
Website
cochlear.com
Headquarters
Sydney
Founded
1983
ISIN
AU000000COH5
FIGI
BBG000K9SMQ0
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment deals with the treatment pathway for acquired or progressive hearing loss. The Services segment offers sound processor upgrades, accessories, and others. The Acoustic segment is for the bone conduction systems. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Check out other big names from the same industry as OC5.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OC5 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of OC5 is 167.04 EUR — it has decreased by −0.01% in the past 24 hours. Watch COCHLEAR LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange COCHLEAR LTD stocks are traded under the ticker OC5.
OC5 stock has fallen by −2.37% compared to the previous week, the month change is a −4.19% fall, over the last year COCHLEAR LTD has showed a −9.05% decrease.
We've gathered analysts' opinions on COCHLEAR LTD future price: according to them, OC5 price has a max estimate of 197.86 EUR and a min estimate of 154.79 EUR. Watch OC5 chart and read a more detailed COCHLEAR LTD stock forecast: see what analysts think of COCHLEAR LTD and suggest that you do with its stocks.
OC5 reached its all-time high on Feb 29, 2024 with the price of 210.36 EUR, and its all-time low was 10.70 EUR and was reached on Aug 18, 2004. View more price dynamics on OC5 chart.
See other stocks reaching their highest and lowest prices.
OC5 stock is 0.01% volatile and has beta coefficient of 0.46. Track COCHLEAR LTD stock price on the chart and check out the list of the most volatile stocks — is COCHLEAR LTD there?
Today COCHLEAR LTD has the market capitalization of ‪10.90 B‬, it has decreased by −5.42% over the last week.
Yes, you can track COCHLEAR LTD financials in yearly and quarterly reports right on TradingView.
COCHLEAR LTD is going to release the next earnings report on Feb 18, 2026. Keep track of upcoming events with our Earnings Calendar.
OC5 earnings for the last half-year are 1.58 EUR per share, whereas the estimation was 1.65 EUR, resulting in a −3.80% surprise. The estimated earnings for the next half-year are 1.74 EUR per share. See more details about COCHLEAR LTD earnings.
COCHLEAR LTD revenue for the last half-year amounts to ‪662.00 M‬ EUR, despite the estimated figure of ‪665.06 M‬ EUR. In the next half-year revenue is expected to reach ‪682.11 M‬ EUR.
OC5 net income for the last half-year is ‪102.60 M‬ EUR, while the previous report showed ‪122.57 M‬ EUR of net income which accounts for −16.29% change. Track more COCHLEAR LTD financial stats to get the full picture.
COCHLEAR LTD dividend yield was 1.43% in 2025, and payout ratio reached 72.35%. The year before the numbers were 1.23% and 75.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 25, 2025, the company has ‪5.5 K‬ employees. See our rating of the largest employees — is COCHLEAR LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COCHLEAR LTD EBITDA is ‪334.71 M‬ EUR, and current EBITDA margin is 25.45%. See more stats in COCHLEAR LTD financial statements.
Like other stocks, OC5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COCHLEAR LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COCHLEAR LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COCHLEAR LTD stock shows the sell signal. See more of COCHLEAR LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.